RT Journal Article SR Electronic T1 Dual antiplatelet therapy for acute coronary syndromes: How long to continue? JF Cleveland Clinic Journal of Medicine JO Cleve Clin J Med FD Cleveland Clinic SP 675 OP 688 DO 10.3949/ccjm.83a.15092 VO 83 IS 9 A1 Meghana Halkar A1 A. Michael Lincoff YR 2016 UL http://www.ccjm.org/content/83/9/675.abstract AB For patients with an acute coronary syndrome event, current guidelines recommend dual antiplatelet therapy for at least 12 months after drug-eluting stent placement. However, several clinical trials have assessed whether continuing dual antiplatelet therapy beyond 12 months is beneficial. We review the pros and cons of extending dual antiplatelet therapy.